96 related articles for article (PubMed ID: 35881043)
1. Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study.
Necchi A; Spiess PE; Bandini M; Basile G; Grivas P; Bratslavsky G; Jacob J; Danziger N; Lin D; Decker B; Sokol ES; Huang RSP; Kulkarni SB; Ross JS
Oncologist; 2022 Dec; 27(12):1016-1024. PubMed ID: 35881043
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI; Ryan CJ; McKay RR; Master VA; Bilen MA
Cancer; 2023 Dec; 129(24):3884-3893. PubMed ID: 37565840
[TBL] [Abstract][Full Text] [Related]
3. HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study.
Ghelani GH; Zerdan MB; Jacob J; Spiess PE; Li R; Necchi A; Grivas P; Kamat A; Danziger N; Lin D; Huang R; Decker B; Sokol ES; Cheng L; Pavlick D; Ross JS; Bratslavsky G; Basnet A
Urol Oncol; 2023 Dec; 41(12):486.e15-486.e23. PubMed ID: 37821306
[TBL] [Abstract][Full Text] [Related]
4. Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden.
Necchi A; Spiess PE; Costa de Padua T; Li R; Grivas P; Huang RSP; Lin DI; Danziger N; Ross JS; Jacob JM; Sager RA; Basnet A; Li G; Graf RP; Pavlick DC; Bratslavsky G
JAMA Netw Open; 2023 Dec; 6(12):e2348002. PubMed ID: 38150257
[TBL] [Abstract][Full Text] [Related]
5. High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases.
Hrudka J; Hojný J; Prouzová Z; Kendall Bártů M; Čapka D; Zavillová N; Matěj R; Waldauf P
Pathology; 2024 Apr; 56(3):357-366. PubMed ID: 38161143
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
Huang RSP; Li X; Haberberger J; Sokol E; Severson E; Duncan DL; Hemmerich A; Edgerly C; Williams E; Elvin J; Vergilio JA; Killian JK; Lin D; Hiemenz M; Xiao J; McEwan D; Holmes O; Danziger N; Erlich R; Frampton G; Cohen MB; McGregor K; Reddy P; Cardeiro D; Anhorn R; Venstrom J; Alexander B; Brown C; Pusztai L; Ross JS; Ramkissoon SH
Oncologist; 2020 Nov; 25(11):943-953. PubMed ID: 32869930
[TBL] [Abstract][Full Text] [Related]
7. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma.
Tekin B; Cheville JC; Herrera Hernandez L; Negron V; Smith CY; Jenkins SM; Dasari S; Enninga EAL; Norgan AP; Menon S; Cubilla AL; Whaley RD; Jimenez RE; Thompson RH; Leibovich BC; Karnes RJ; Boorjian SA; Pagliaro LC; Erickson LA; Guo R; Gupta S
Hum Pathol; 2023 Dec; 142():42-50. PubMed ID: 37977513
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome.
Gordinier ME; Schau GF; Pollock SB; Shields LBE; Talwalkar S
Gynecol Oncol; 2024 Jan; 180():111-117. PubMed ID: 38086165
[TBL] [Abstract][Full Text] [Related]
9. NOTCH1 and PIK3CA mutation are related to HPV-associated vulvar squamous cell carcinoma.
Choschzick M; Stergiou C; Gut A; Zoche M; Ross JS; Moch H
Pathol Res Pract; 2023 Nov; 251():154877. PubMed ID: 37839360
[TBL] [Abstract][Full Text] [Related]
10. Immune landscape and immunotherapy for penile cancer.
Tang Y; Hu X; Wu K; Li X
Front Immunol; 2022; 13():1055235. PubMed ID: 36524123
[TBL] [Abstract][Full Text] [Related]
11. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix.
Cimic A; Vranic S; Arguello D; Contreras E; Gatalica Z; Swensen J
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):299-304. PubMed ID: 33208671
[TBL] [Abstract][Full Text] [Related]
12. Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: potential therapeutic targets.
Dong Z; Chong W; Chen C; Qi L; Mengke L; Minghui D; Jiawei Y; Longxi Q; Hengchao L; Liu J; Zhimin G
BMC Cancer; 2024 Mar; 24(1):286. PubMed ID: 38439030
[TBL] [Abstract][Full Text] [Related]
13. Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.
Chung JH; Dewal N; Sokol E; Mathew P; Whitehead R; Millis SZ; Frampton GM; Bratslavsky G; Pal SK; Lee RJ; Necchi A; Gregg JP; Lara P; Antonarakis ES; Miller VA; Ross JS; Ali SM; Agarwal N
JCO Precis Oncol; 2019; 3():. PubMed ID: 31218271
[TBL] [Abstract][Full Text] [Related]
14. Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
Leary JB; Enright T; Bakaloudi DR; Basnet A; Bratslavsky G; Jacob J; Spiess PE; Li R; Necchi A; Kamat AM; Pavlick DC; Danziger N; Huang RSP; Lin DI; Cheng L; Ross J; Talukder R; Grivas P
Target Oncol; 2024 May; 19(3):447-458. PubMed ID: 38570422
[TBL] [Abstract][Full Text] [Related]
15. Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies.
Goodman AM; Kato S; Cohen PR; Boichard A; Frampton G; Miller V; Stephens PJ; Daniels GA; Kurzrock R
Oncoimmunology; 2018; 7(3):e1404217. PubMed ID: 29399405
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma.
Zacharias NM; Segarra L; Akagi K; Fowlkes NW; Chen H; Alaniz A; de la Cerda C; Pesquera P; Xi Y; Wang J; Chahoud J; Lu X; Rao P; Martinez-Ferrer M; Pettaway CA
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473423
[TBL] [Abstract][Full Text] [Related]
17. Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics.
Xi Q; Kage H; Ogawa M; Matsunaga A; Nishijima A; Sone K; Kawana K; Oda K
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201563
[TBL] [Abstract][Full Text] [Related]
18. A Targeted, Personalized Management Strategy in Advanced Penile Squamous Cell Carcinoma.
Holland LC; Gerald TS; Brooks B; Margulis V
Urology; 2024 Feb; 184():71-74. PubMed ID: 38056508
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study.
Blansky D; Ansari N; Gao L; Sokol ES; Sivakumar S; Huang RSP; Pelletier M; Levy M; Pavlick D; Danziger N; Ross JS; Lustberg M; Rozenblit M
Breast Cancer Res Treat; 2024 Feb; 204(1):181-185. PubMed ID: 37999916
[TBL] [Abstract][Full Text] [Related]
20. Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies.
Safa H; Mercinelli C; Spiess PE; Necchi A; Chahoud J
Expert Opin Pharmacother; 2024 Mar; 25(4):447-465. PubMed ID: 38549550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
